C-peptide and zinc delivery to erythrocytes requires the presence of albumin: Implications in diabetes explored with a 3D-printed fluidic device

Integrative Biology

Volumn 7, Issue 5, 2015, Pages 534-543

  Liu, Yueli ^a   Chen, Chengpeng ^a   Summers, Suzanne ^a   Medawala, Wathsala ^a   Spence, Dana M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALBUMIN; C PEPTIDE; INSULIN; NITRIC OXIDE; ZINC; ALBUMINOID; PEPTIDE;

ARTICLE; CELL COMMUNICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; ERYTHROCYTE; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; ISOTHERMAL TITRATION CALORIMETRY; MICROFLUIDICS; PANCREAS ISLET BETA CELL; PH; PRIORITY JOURNAL; PROTEIN BINDING; STOICHIOMETRY; ANIMAL; CALORIMETRY; CELL LINE; CHEMISTRY; CYTOLOGY; DIABETES MELLITUS, TYPE 1; LAB ON A CHIP; METABOLISM; RAT; THREE DIMENSIONAL PRINTING;

ANIMALIA;

ADENOSINE TRIPHOSPHATE; ALBUMINS; ANIMALS; C-PEPTIDE; CALORIMETRY; CELL COMMUNICATION; CELL LINE; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; HUMANS; INSULIN-SECRETING CELLS; LAB-ON-A-CHIP DEVICES; MICROFLUIDICS; PEPTIDES; PRINTING, THREE-DIMENSIONAL; RATS; ZINC;

EID: 84929152386     PISSN: 17579694     EISSN: 17579708     Source Type: Journal    
DOI: 10.1039/c4ib00243a     Document Type: Article

References (45)

1. Fast Facts: Data and Statistics about Diabetes, American Diabetes Association, 2013
2. G. Danaei M. M. Finucane Y. Lu G. M. Singh M. J. Cowan C. J. Paciorek J. K. Lin F. Farzadfar Y. H. Khang G. A. Stevens M. Rao M. K. Ali L. M. Riley C. A. Robinson M. Ezzati on behalf of the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose), National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants Lancet 2011 378 31 40 10.1016/S0140-6736(11)60679-X
3. H. Yki-Jarvinen Combination therapies with insulin in type 2 diabetes Diabetes Care 2001 24 758 767 10.2337/diacare.24.4.758
4. M. J. Fowler Microvascular and Macrovascular Complications of Diabetes Clinical Diabetes 2008 26 77 82
5. G. E. Mcveigh G. M. Brennan G. D. Johnston B. J. Mcdermott L. T. Mcgrath W. R. Henry J. W. Andrews J. R. Hayes Impaired Endothelium-Dependent and Independent Vasodilation in Patients with Type-2 (Non-Insulin-Dependent) Diabetes-Mellitus Diabetologia 1992 35 771 776
6. S. B. Williams J. A. Cusco M. A. Roddy M. T. Johnstone M. A. Creager Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus J. Am. Coll. Cardiol. 1996 27 567 574 10.1016/0735-1097(95)00522-6
7. P. A. Low J. D. Schmelzer K. K. Ward G. L. Curran J. F. Poduslo Effect of Hyperbaric Oxygenation on Normal and Chronic Streptozotocin Diabetic Peripheral-Nerves Exp. Neurol. 1988 99 201 212 10.1016/0014-4886(88)90139-2
8. E. A. Pierce R. L. Avery E. D. Foley L. P. Aiello L. E. H. Smith Vascular Endothelial Growth-Factor Vascular-Permeability Factor Expression in a Mouse Model of Retinal Neovascularization Proc. Natl. Acad. Sci. U. S. A. 1995 92 905 909 10.1073/pnas.92.3.905
9. P. A. Craven M. A. Caines F. R. Derubertis Sequential Alterations in Glomerular Prostaglandin and Thromboxane Synthesis in Diabetic Rats-Relationship to the Hyperfiltration of Early Diabetes Metab., Clin. Exp. 1987 36 95 103 10.1016/0026-0495(87)90070-9
10. A. H. Rubenstein J. L. Clark F. Malani D. F. Steiner Secretion of Proinsulin C-Peptide by Pancreatic Beta Cells and Its Circulation in Blood Nature 1969 224 697 699 10.1038/224697a0
11. D. F. Steiner Role of Proinsulin C-Peptide Diabetes 1978 27 145 148
12. J. Wahren K. Ekberg H. Jornvall C-peptide is a bioactive peptide Diabetologia 2007 50 503 509 10.1007/s00125-006-0559-y
13. S. Sjoberg M. Gjotterberg L. Berglund E. Moller J. Ostman Residual C-peptide excretion is associated with a better long-term glycemic control and slower progress of retinopathy in type I (insulin-dependent) diabetes mellitus J. Diabetes Complications 1991 5 18 22
14. B. L. Johansson S. Sjoberg J. Wahren The Influence of Human C-Peptide on Renal-Function and Glucose-Utilization in Type-1 (Insulin-Dependent) Diabetic-Patients Diabetologia 1992 35 121 128 10.1007/Bf00402543
15. B. L. Johansson A. Kernell S. Sjoberg J. Wahren Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1 J. Clin. Endocrinol. Metab. 1993 77 976 981 10.1210/jcem.77.4.8408474
16. T. Forst T. Kunt Effects of C-peptide on microvascular blood flow and blood hemorheology Exp. Diabesity Res. 2004 5 51 64 10.1080/15438600490424532
17. B. L. Johansson K. Borg E. Fernqvist-Forbes A. Kernell T. Odergren J. Wahren Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus Diabetic Med. 2000 17 181 189 10.1046/j.1464-5491.2000.00274.x
18. A. A. F. Sima H. Kamiya Is C-peptide replacement the missing link for successful treatment of neurological complications in type 1 diabetes? Curr. Drug Targets 2008 9 37 46 10.2174/138945008783431745
19. J. A. Meyer J. M. Froelich G. E. Reid W. K. Karunarathne D. M. Spence Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter Diabetologia 2008 51 175 182 10.1007/s00125-007-0853-3
20. J. P. Richards A. H. Stephenson M. L. Ellsworth R. S. Sprague Synergistic effects of C-peptide and insulin on low O-2-induced ATP release from human erythrocytes Am. J. Physiol. 2013 305 R1331 R1336 10.1152/ajpregu.00341.2013
21. J. A. Meyer W. Subasinghe A. A. F. Sima Z. Keltner G. E. Reid D. Daleke D. M. Spence Zinc-activated C-peptide resistance to the type 2 diabetic erythrocyte is associated with hyperglycemia-induced phosphatidylserine externalization and reversed by metformin Mol. BioSyst. 2009 5 1157 1162 10.1039/B908241g
22. S. Takayama E. Ostuni P. LeDuc K. Naruse D. E. Ingber G. M. Whitesides Selective chemical treatment of cellular microdomains using multiple laminar streams Chem. Biol. 2003 10 123 130 10.1016/S1074-5521(03)00019-X
23. R. S. Kane S. Takayama E. Ostuni D. E. Ingber G. M. Whitesides Patterning proteins and cells using soft lithography Biomaterials 1999 20 2363 2376 10.1016/S0142-9612(99)00165-9
24. L. I. Genes N. V. Tolan M. K. Hulvey R. S. Martin D. M. Spence Addressing a vascular endothelium array with blood components using underlying microfluidic channels Lab Chip 2007 7 1256 1259 10.1039/B712619k
25. C. J. Ku T. D. Oblak D. M. Spence Interactions between multiple cell types in parallel microfluidic channels: Monitoring platelet adhesion to an endothelium in the presence of an anti-adhesion drug Anal. Chem. 2008 80 7543 7548 10.1021/Ac801114j
26. D. Huh H. J. Kim J. P. Fraser D. E. Shea M. Khan A. Bahinski G. A. Hamilton D. E. Ingber Microfabrication of human organs-on-chips Nat. Protoc. 2013 8 2135 2157 10.1038/nprot.2013.137
27. B. C. Gross J. L. Erkal S. Y. Lockwood C. P. Chen D. M. Spence Evaluation of 3D Printing and Its Potential Impact on Biotechnology and the Chemical Sciences Anal. Chem. 2014 86 3240 3253 10.1021/Ac403397r
28. J. Wahren A. Kallas A. A. F. Sima The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes Diabetes 2012 61 761 772 10.2337/Db11-1423
29. A. A. F. Sima Diabetes & C-Peptide Scientific and Clinical Aspects Conclusions and Future Outlook Diabetes & C-Peptide: Scientific and Clinical Aspects 2012 161 163 10.1007/978-1-61779-391-2-14
30. T. Forst D. D. De la Tour T. Kunt A. Pfutzner K. Goitom T. Pohlmann S. Schneider B. L. Johansson J. Wahren M. Lobig M. Engelbach J. Beyer P. Vague Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I Clin. Sci. 2000 98 283 290 10.1042/Cs19990241
31. R. S. Chima G. Maltese T. LaMontagne G. Piraino A. Denenberg M. O'Connor B. Zingarelli C-Peptide Ameliorates Kidney Injury Following Hemorrhagic Shock Shock 2011 35 524 529 10.1097/Shk.0b013e31820b2e98
32. L. Luzi G. Zerbini A. Caumo C-peptide: a redundant relative of insulin? Diabetologia 2007 50 500 502 10.1007/s00125-006-0576-x
33. R. Rigler A. Pramanik P. Jonasson G. Kratz O. T. Jansson P. A. Nygren S. Stahl K. Ekberg B. L. Johansson S. Uhlen M. Uhlen H. Jornvall J. Wahren Specific binding of proinsulin C-peptide to human cell membranes Proc. Natl. Acad. Sci. U. S. A. 1999 96 13318 13323 10.1073/pnas.96.23.13318
34. M. E. Baker Albumin's role in steroid hormone action and the origins of vertebrates: is albumin an essential protein? FEBS Lett. 1998 439 9 12 10.1016/S0014-5793(98)01346-5
35. F. Kratz Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles J. Controlled Release 2008 132 171 183 10.1016/j.jconrel.2008.05.010
36. G. J. van der Vusse Albumin as Fatty Acid Transporter Drug Metab. Pharmacokinet. 2009 24 300 307
37. M. Henriksson E. Nordling E. Melles J. Shafqat M. Stahlberg K. Ekberg B. Persson T. Bergman J. Wahren J. Johansson H. Jornvall Separate functional features of proinsulin C-peptide Cell. Mol. Life Sci. 2005 62 1772 1778 10.1007/s00018-005-5180-6
38. A. Pramanik K. Ekberg Z. Zhong J. Shafqat M. Henriksson O. Jansson A. Tibell M. Tally J. Wahren H. Jornvall R. Rigler J. Johnansson C-peptide binding to human cell membranes: Importance of Glu27 Biochem. Biophys. Res. Commun. 2001 284 94 98 10.1006/bbrc.2001.4917
39. T. Hach T. Forst T. Kunt K. Ekberg A. Pfutzner J. Wahren C-Peptide and Its C-Terminal Fragments Improve Erythrocyte Deformability in Type 1 Diabetes Patients Exp. Diabetes Res. 2008 730594 10.1155/2008/730594
40. S. Slinko G. Piraino P. W. Hake J. R. Ledford M. O'Connor P. Lahni P. D. Solan H. R. Wong B. Zingarelli Combined Zinc Supplementation with Proinsulin C-Peptide Treatment Decreases the Inflammatory Response and Mortality in Murine Polymicrobial Sepsis Shock 2014 41 292 300 10.1097/Shk.0000000000000127
41. J. P. Richards E. A. Bowles W. R. Gordon M. L. Ellsworth A. H. Stephenson R. S. Sprague Mechanisms of C-Peptide-Mediated Rescue of Low O2-Induced ATP Release from Erythrocytes of Humans with Type 2 Diabetes Am. J. Physiol.: Regul., Integr. Comp. Physiol. 2015 308 R411 R418 10.1152/ajpregu.00420.2014
42. J. P. Richards G. L. Yosten G. R. Kolar C. W. Jones A. H. Stephenson M. L. Ellsworth R. S. Sprague Low O2-induced ATP release from erythrocytes of humans with type 2 diabetes is restored by physiological ratios of C-peptide and insulin Am. J. Physiol.: Regul., Integr. Comp. Physiol. 2014 307 R862 R868 10.1152/ajpregu.00206.2014
43. J. P. Richards A. H. Stephenson M. L. Ellsworth R. S. Sprague Synergistic effects of C-peptide and insulin on low O2-induced ATP release from human erythrocytes Am. J. Physiol.: Regul., Integr. Comp. Physiol. 2013 305 R1331 R1336 10.1152/ajpregu.00341.2013
44. W. Medawala P. McCahill A. Giebink J. Meyer C. J. Ku D. M. Spence A Molecular Level Understanding of Zinc Activation of C-peptide and its Effects on Cellular Communication in the Bloodstream Rev. Diabetic Study 2009 6 148 158 10.1900/RDS.2009.6.148
45. C. P. Chen Y. M. Wang S. Y. Lockwood D. M. Spence 3D-printed fluidic devices enable quantitative evaluation of blood components in modified storage solutions for use in transfusion medicine Analyst 2014 139 3219 3226 10.1039/C3an02357e